Skip to main content
Premium Trial:

Request an Annual Quote

Kenneth Bloom, Stephen Schoenberger, and Ezra Cohen

Human Longevity has appointed Kenneth Bloom as head of the oncology and immunotherapy, Stephen Schoenberger as lead on cancer vaccine efforts, and Ezra Cohen as staff oncologist.  Bloom comes to Human Longevity from GE Healthcare where he served as chief medical officer for in vitro diagnostics. He also served as president and CEO of Clarient Pathology Services. Prior to Clarient, Bloom served as senior medical director of US Labs. Schoenberger is currently a professor in cellular immunology at the La Jolla Institute for Allergy and Immunology and an adjunct professor of medicine in the division of hematology and oncology at the University of California, San Diego's Moores Cancer Center. Cohen co-leads the Solid Tumor Therapeutics program at the Moores Cancer Center. He also serves as co-chair of the National Cancer Institute Head and Neck Cancer Steering Committee.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.